Zecs now your trolling hard and down playing everything the company achieved so far. Lies lol your the troll:
1. Human studies start in around 4 weeks and we will know of side effect profiles from day 10 of study 2. Company has passed all preclinical studies and safety studies to get to humans which heavily derisk the phase 1 study 3. only drug in the world to treat primary, secondary and protect the heart all at once 4. patent has been submitted back in August 5. Non dilutive funding comes from the CEO interviews not me 6. Funding for phase 1 because it’s acute treatment like AGN is around a 1.5 million dollars. They have around 5 million in the bank so they have the runway 7. brand new drug class and the first of its kind so don’t compare nothing to it 8. peers in the same space are worth 100 million dollar plus market caps on phase 1 clearence and moving onto phase 2
keep posting I’m lying you troll. You’re the one that lost money on this on the fall and sold out and now it’s running again keep posting. Overvalued lol big words go do some research
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)